To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)
Clinical trial NCT04541485 · TERMINATED
Trial details
- NCT number
- NCT04541485
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2021-03-03
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.